Stay updated on Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    An updated page revision tag now displays v3.6.6, replacing the previous v3.6.5. This indicates the ClinicalTrials.gov study page has been refreshed to a newer version.
    Difference
    0.1%
    Check dated 2026-09-01T19:13:28.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5, replacing the previous page version.
    Difference
    0.1%
    Check dated 2026-08-11T08:27:24.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, indicating a small maintenance update to the study record. No substantive changes to the study data or content are indicated.
    Difference
    0.1%
    Check dated 2026-07-28T04:58:59.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.6.2 to v3.6.3. This indicates a new version of the entry rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-06T16:48:26.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The page shows a new revision label v3.6.2. This indicates a frontend update rather than changes to the study information.
    Difference
    0.1%
    Check dated 2026-06-29T09:58:46.000Z thumbnail image
  9. Check
    88 days ago
    Change Detected
    Summary
    The page now indicates that recruitment is closed, and new help/navigation items were added along with a formatting tweak to the Intervention/Treatment header and a revision note showing v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-15T07:56:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page.